[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601850":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":70,"collaborators":73,"id":79,"slug":24,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":24,"eligibilityCriteria":84,"healthyVolunteers":80,"sex":85,"minAge":86,"maxAge":24,"enrollmentInfo":87,"targetDuration":24,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":24,"overallStatus":59,"whyStopped":24,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University of California, Los Angeles","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","Participants in this arm will be consuming 237 ml of pomegranate juice for the first 8 weeks of the study and their habitual diet without pomegranate juice for the second 8 weeks",[13],"Other: pomegranate juice -> habitual diet",{"label":15,"type":10,"description":16,"interventionNames":17},"Delayed start","Participants in this arm will consume their habitual diet for the first 8 weeks of the study and drink 237 ml of pomegranate juice for the second 8 weeks",[18],"Other: habitual diet -> pomegranate juice",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"pomegranate juice -> habitual diet","237 ml of pomegranate juice for the first 8 weeks -\\> habitual diet for the second 8 weeks",[9],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"habitual diet -> pomegranate juice","habitual diet for the first 8 weeks -\\> 237 ml of pomegranate juice for the second 8 weeks",[15],[30],{"name":31,"affiliation":5,"role":32},"Zhaoping Li, MD, PhD","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":24,"email":38},"Tatiana Diacova, PhD, MS, RDN","CONTACT","310-206-8292","tdiacova@mednet.ucla.edu",[40,57],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"West Los Angeles VA Medical Center","NOT_YET_RECRUITING","Los Angeles","California","90073","United States",{"type":48,"coordinates":49},"Point",[50,51],-118.24368,34.05223,{"lat":51,"lon":50},[54,56],{"name":55,"role":36,"phone":37,"phoneExt":24,"email":38},"Tatiana Diacova, PhD, MS, RD",{"name":31,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":58,"status":59,"city":43,"state":44,"zip":60,"country":46,"cosmosGeoPoint":61,"geoPoint":63,"contacts":64},"UCLA Center for Human Nutrition","RECRUITING","90095",{"type":48,"coordinates":62},[50,51],{"lat":51,"lon":50},[65,66,67],{"name":55,"role":36,"phone":37,"phoneExt":24,"email":38},{"name":31,"role":32,"phone":24,"phoneExt":24,"email":24},{"name":68,"role":69,"phone":24,"phoneExt":24,"email":24},"Berkeley Limketkai, MD, PhD","SUB_INVESTIGATOR",{"type":32,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Zhaoping Li","Principal Investigator",[74,77],{"name":75,"class":76},"National Institutes of Health (NIH)","NIH",{"name":78,"class":76},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","100601850",false,"NCT07115862","Effects of Pomegranate Juice on Ulcerative Colitis","Effect of Pomegranate Juice on Gut Inflammation, Quality of Life and the Gut Microbiome in Patients With Ulcerative Colitis: A Pilot Study","Inclusion Criteria:\n\n* • Adults ≥ 18 yo\n\n  * Following a low-polyphenol and fiber diet (\\\u003C 3 servings of fruits\u002Fvegetables per day)\n  * Mild-to-moderate UC at the time of screening (2 ≤ partial Mayo scores ≤ 5)\n  * Supportive evidence of active inflammation (hsCRP \\>1 mg\u002FL, fecal calprotectin \\>50 µg\u002Fg stool, or abnormal lower endoscopy) in individuals with biopsy-proven UC\n  * Patients on 5-aminosalicylates must be on a stable dose for ≥ 4 weeks prior to screening\n  * Patients on treatment with immunosuppressive therapy (e.g., azathioprine\u002F6-mercaptopurine, methotrexate) must be on stable dose for 8 weeks prior to baseline visit\n  * At the time of baseline visit, patients may be on no more than 20 mg\u002Fday of prednisone and 9 mg\u002Fday of budesonide MMX\n  * Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.\n\nExclusion Criteria:\n\n* • Non-English speaker\n\n  * Vegetarian\u002Fvegan\n  * Known pomegranate allergy\n  * Documented chronic disease besides UC, including diabetes, renal or liver diseases, metabolic syndrome, active cancer, MI or stroke, history of gastric bypass\n  * Patients with CD, indeterminate\u002Fsevere to fulminant colitis\n  * History of colectomy or colonic dysplasia\n  * Presence of ileal pouch or ostomy\n  * Evidence of active bacterial or viral gastroenteritis as indicated by positive stool studies for ova \\& parasites, Clostridium difficile, and stool culture\n  * Recent hospitalizations (within 2 weeks of screening) for UC requiring IV steroids\n  * Presence of the following labs indicative of severe colitis: a. Hemoglobin \\\u003C 8.0 g\u002Fdl b. Albumin \\\u003C 3.0 g\u002Fdl\n  * Recent systemic antibiotics use (within 3 months of screening) or active use of anti-diarrheal medications\n  * Taking supplements known to affect metabolism or gut microbiota composition (probiotics, fiber, etc.), unless willing to stop for the study duration\n  * Use of Total Parenteral Nutrition (TPN)\n  * Use of cyclosporine, tacrolimus, or thalidomide within 2 months prior to screening\n  * Taking exogenous hormones (e.g., hormone replacement therapy)\n  * Recent weight fluctuations (\\>10% in the last 6 months)\n  * Smoker or living with a smoker\n  * Use of \\>20 g of alcohol per day\n  * Unable or unwilling to comply with the study protocol (including unwillingness to avoid watermelon and other lycopene-rich foods for the whole duration of the study)\n  * Unable to provide consent","ALL","18 Years",{"count":88,"type":89},30,"ESTIMATED","INTERVENTIONAL",[92],"NA","The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will:\n\n1. lower inflammation (in the gut as well as generally in the body) and improve your overall quality of life\n2. affect the microbes living in the gut (gut microbiota)",[95],"Ulcerative Colitis (Disorder)","2025-12-08",{"date":98,"type":99},"2025-12-09","ACTUAL",{"date":101,"type":99},"2025-10-15",{"date":103,"type":89},"2027-10-15",{"name":5,"class":6},2]